Clik here to view.
EP Vantage Releases Its Annual Analysis of Pharma & Biotech and Medtech...
LONDON & BOSTON & SAN FRANCISCO & TOKYO Funding for early stage biopharma and medtech research dwindled in 2015, as investors shifted their support to more mature companies. These...
View ArticleClik here to view.
Premier Biomedical, Inc. Engages Agent to Identify Suitable Joint Venture...
EL PASO, Texas Premier Biomedical, Inc. (OTCQB: BIEI) announced that they have engaged the services of an agent affiliated with the Chinese pharmaceutical industry to seek out suitable joint venture...
View ArticleClik here to view.
富盛国际事业正式完美启航
金边, 柬埔寨 (美国商业资讯)–富盛国际控股集团Rorine International Corporation Holding (Company Number:9353333)在美国OTC Markets 上巿(RIHC)并引领集团属下公司： Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
Announcement: RIHC Sets Sail for Global Business
PHNOM PENH, Cambodia Rorine International Holding Corporation (Company Number: 9353333) has been listed (RIHC) on OTC markets in America and RIHC subsidiaries include:- This Smart News Release...
View ArticleClik here to view.
Apira Science的iGrow成为中国国家食品药品监督管理局(CFDA)核准的首个毛发生长器械
佛罗里达州博卡拉顿 (美国商业资讯) — Apira Science,...
View ArticleClik here to view.
アピラ・サイエンスのiGrowが中国国家食品薬品監督管理局（CFDA）から承認された初の育毛装置に
米フロリダ州ボカラトン （ビジネスワイヤ） — アピラ・サイエンスは、 iGrow育毛システムの中国での承認を受けて、世界的拡張を続けています。iGrowは中国国家食品薬品監督管理局（CFDA）から承認された唯一の育毛装置であるばかりでなく、米国FDAとCFDAのいずれからも承認された唯一の装置でもあります。アピラは国中医薬有限責任公司（China Central...
View ArticleClik here to view.
Cantargia AB: Cantargia Receives Patent Approval in Japan and Mexico
STOCKHOLM Cantargia AB (“Cantargia”) has received approval in Japan and Mexico for its patent application covering IL1RAP as a target molecule for antibody therapy and leukemia diagnostics. The...
View ArticleClik here to view.
AVEO and CANbridge Life Sciences Announce Exclusive Licensing Agreement for...
CAMBRIDGE, Mass. & BEIJING AVEO Oncology (NASDAQ:AVEO) and CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, today...
View ArticleClik here to view.
Chi-Med Initiates Sulfatinib Phase III Registration Study in Pancreatic...
LONDON Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that Hutchison MediPharma Limited (“HMP”), its drug R&D subsidiary, has initiated SANET-p, a Phase III...
View ArticleClik here to view.
がん治療法は自分で選べる時代がん免疫細胞療法セミナー、福岡市で開催、参加者を募集：リンパ球バンク株式会社
東京 （ビジネスワイヤ） — がん免疫治療で先進的な取り組みをしている京都大学発のベンチャー企業、リンパ球バンク株式会社（本社：東京都千代田区、代表取締役：藤井真則）は、今、注目を集めているがん免疫治療について広く知っていただくため、読売新聞西部本社後援・市民公開講座「がん免疫細胞療法セミナー」を4月6日（水）福岡市中央区の読売新聞西部本社にて開催します。先着80名様で参加希望者を募集中です。...
View ArticleClik here to view.
CORRECTING and REPLACING Announcement: RIHC Sets Sail for Global Business
PHNOM PENH, Cambodia In the list of subsidiaries, the release previously issued March 18, 2016 should read: Guangzhou Lu Sheng Health Consultancy Co. Ltd. (instead of Guangzhou Lv Sheng Health...
View ArticleClik here to view.
注意-更正并替换：富盛国际事业正式完美启航
金边, 柬埔寨 (美国商业资讯)–富盛国际控股集团Rorine International Corporation Holding (Company Number:9353333)在美国OTC Markets 上巿(RIHC)并引领集团属下公司： Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
Sosei Appoints Peter Bains as COO and CEO-elect
TOKYO Sosei Group Corporation (“Sosei”; TOKYO Mothers Index: 4565) today announces the appointment of Mr Peter Bains as Representative Executive Officer and Chief Operating Officer (COO) effective...
View ArticleClik here to view.
Agilis Biotherapeutics and T-TOP Clinical Research Enter into an Agreement...
CAMBRIDGE, Mass. Agilis Biotherapeutics, LLC (Agilis), a biotechnology company advancing innovative gene therapies for rare genetic diseases that affect the central nervous system (CNS), and T-TOP...
View ArticleClik here to view.
Quintiles Honored as ‘Best CRO in Asia’ for Fourth Time in Six Years
SINGAPORE Quintiles last night was named the “Best CRO in Asia” at the 2016 BioPharma Asia Industry Awards, winning the honor for the fourth time in the event’s six-year history. The award goes to...
View ArticleClik here to view.
LCT Starts Phase IIb Clinical Trial of NTCELL for Parkinson’s Disease
SYDNEY & AUCKLAND, New Zealand Living Cell Technologies has received approval from the Auckland Hospital Research Review Committee for the Phase IIb clinical trial of NTCELL® for Parkinson’s...
View ArticleClik here to view.
Enhance Your Expertise in Forensic DNA at the 2016 International Symposium on...
MADISON, Wis. Forensic professionals interested in learning about the latest developments in forensic DNA tools, techniques and processes are invited to join scientists, law enforcement...
View ArticleClik here to view.
Hotel Nikko Taizhou Opens April 1
TOKYO Okura Nikko Hotel Management Co., Ltd. announced today the opening of Hotel Nikko Taizhou on April 1. The luxury hotel is located in the center of Taizhou National Medical High-tech...
View ArticleClik here to view.
ZOLL Receives Approval to Market Intravascular Temperature Management...
CHELMSFORD, Mass. ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that its Japanese subsidiary, Asahi Kasei...
View ArticleClik here to view.
クインタイルズが6年間で4度目となる「アジア・ベストCRO」を受賞
シンガポール （ビジネスワイヤ） — クインタイルズは昨夜、2016バイオファーマ・アジア業界賞の「アジア・ベストCRO」に選出されました。受賞は同イベントの6年間の歴史で4度目となる栄誉です。この賞は、アジアで臨床研究サービスの改善と、顧客リードタイムの短縮への継続的なコミットメントを最もよく示している医薬品開発業務受託機関に与えられるものです。...
View Article